Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysis

BACKGROUND: SLE is an autoimmune disease marked by broad immunological dysregulation and multi-system inflammation. Baricitinib is one of the novel treatments for SLE. We conducted this meta-analysis to evaluate its safety and effectiveness in treating SLE. METHOD: We looked for all published random...

Descripción completa

Detalles Bibliográficos
Autores principales: Allam, Abdallah R., Alhateem, Mohamed Salah, Mahmoud, Abdelrahman Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617176/
https://www.ncbi.nlm.nih.gov/pubmed/37904221
http://dx.doi.org/10.1186/s41927-023-00363-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617176/
https://www.ncbi.nlm.nih.gov/pubmed/37904221
http://dx.doi.org/10.1186/s41927-023-00363-6

Ejemplares similares